✦ LIBER ✦

Salvage therapy for prostate cancer recurrence after radiation therapy

✍ Scribed by Jared M. Cox; J. Erik Busby

Publisher: Springer
Year: 2009
Tongue: English
Weight: 264 KB
Volume: 10
Category: Article
ISSN: 1527-2737
DOI: 10.1007/s11934-009-0034-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Salvage therapy for prostate cancer recu

Salvage therapy for prostate cancer recurrence after radiation therapy

✍ Jared M. Cox; J. Erik Busby 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 251 KB

Salvage radical prostatectomy for recurr

Salvage radical prostatectomy for recurrence of prostate cancer after radiation therapy

✍ James A. Eastham; Christopher J. DiBlasio; Peter T. Scardino 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 345 KB

2019 Radiation therapy alone is not succ

2019 Radiation therapy alone is not successful as salvage treatment for locally recurrent prostate cancer after radical, prostatectomy

✍ Lute G. Oas; Gunar K. Zagars; Alan Pollack 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Local recurrence after primary therapy f

Local recurrence after primary therapy for clinically localized prostate cancer: Is radiation or surgery “Better” in the salvage setting?

✍ Christopher G. Wood 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB

Salvage therapy for locally recurrent pr

Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy

✍ Andrew J. Stephenson; Peter T. Scardino; Fernando J. Bianco; James A. Eastham 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 350 KB

Management of prostate cancer recurrence

Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option

✍ Gregory W. Allen; Andrew R. Howard; David F Jarrard; Mark A. Ritter 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB

## Abstract Depending on initial prognostic factors, an estimated 10%–60% of men who undergo definitive radiation therapy for prostate cancer may experience a biochemical recurrence. Even though hormonal therapy is standard for metastatic recurrences, no consensus exists on optimal salvage therapy